Wells Fargo & Company »

Seres Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Seres Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Seres Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seres Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $24k 31k 0.78
2023-12-31 $39k 28k 1.40
2023-09-30 $460k 193k 2.38
2023-06-30 $823k 172k 4.79
2022-12-31 $7.1k 1.3k 5.60
2022-09-30 $26k 4.2k 6.29
2022-06-30 $12k 3.3k 3.61
2022-03-31 $69k 9.7k 7.13
2021-12-31 $275k 33k 8.32
2021-09-30 $372k 55k 6.74
2021-06-30 $775k 29k 26.67
2021-03-31 $1.3M 61k 20.60
2020-12-31 $2.9M 119k 24.49
2020-09-30 $3.8M 136k 28.30
2020-06-30 $459k 96k 4.77
2020-03-31 $292k 82k 3.57
2019-12-31 $253k 73k 3.46
2019-09-30 $267k 66k 4.03
2019-06-30 $128k 40k 3.23
2019-03-31 $139k 20k 6.84
2018-12-31 $47k 10k 4.55
2018-09-30 $79k 10k 7.59
2018-06-30 $84k 9.7k 8.65
2018-03-31 $219k 30k 7.34
2017-12-31 $297k 29k 10.16
2017-06-30 $189k 17k 11.30
2017-03-31 $345k 31k 11.30
2016-12-31 $962k 97k 9.89
2016-09-30 $75k 6.1k 12.23
2016-06-30 $187k 6.4k 29.02
2016-03-31 $129k 4.8k 26.57
2015-12-31 $153k 4.4k 35.04
2015-09-30 $999 35 28.57